TENX

$0.00

(

0.00%

)
Quote details

stock

Tenax Therapeutics Inc

NASDAQ | TENX

7.41

USD

$0.00

(

0.00%

)

At Close (As of Oct 13, 2025)

$34.04M

Market Cap

2.537

P/E Ratio

2.94

EPS

$8.24

52 Week High

$3.61

52 Week Low

HEALTHCARE

Sector

TENX Chart

Recent Chart
Price Action

TENX Technicals

Tags:

TENX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$19M
Selling General And Administrative $6.8M
Research And Development $13M
Operating Expenses $19M
Investment Income Net -
Net Interest Income $1.9M
Interest Income $1.9M
Interest Expense $23K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $46K
Income Before Tax -$18M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$18M
Comprehensive Income Net Of Tax -
Ebit -$18M
Ebitda -$18M
Net Income -$18M

Revenue & Profitability

Earnings Performance

TENX Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $97M
Total Current Assets $97M
Cash And Cash Equivalents At Carrying Value $95M
Cash And Short Term Investments $95M
Inventory -
Current Net Receivables -
Total Non Current Assets $0
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $1.8M
Other Non Current Assets -
Total Liabilities $4.7M
Total Current Liabilities $4.7M
Current Accounts Payable $3.2M
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $0
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total -
Other Current Liabilities $1.5M
Other Non Current Liabilities -
Total Shareholder Equity $92M
Treasury Stock -
Retained Earnings -$315M
Common Stock -
Common Stock Shares Outstanding $15M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$15M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $0
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $100M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$18M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$19M
Selling General And Administrative $6.8M
Research And Development $13M
Operating Expenses $19M
Investment Income Net -
Net Interest Income $1.9M
Interest Income $1.9M
Interest Expense $23K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $46K
Income Before Tax -$18M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$18M
Comprehensive Income Net Of Tax -
Ebit -$18M
Ebitda -$18M
Net Income -$18M

TENX News

TENX Profile

Tenax Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Tenax Therapeutics, Inc. is a specialty pharmaceutical firm focused on the advancement of innovative therapies for cardiovascular and pulmonary diseases, catering primarily to the U.S. and Canadian markets. Headquartered in Morrisville, North Carolina, the company aims to address unmet medical needs through its proprietary drug development pipeline, which includes products aimed at improving patient outcomes in critical care settings. With a commitment to enhancing treatment options in the cardiovascular and pulmonary sectors, Tenax Therapeutics is poised for growth as it leverages its expertise and research capabilities to bring novel therapeutics to market.

VHAI
-25.00%
$0.00
YYAI
-12.69%
$0.16
STAI
+39.44%
$0.62
CGBS
-39.47%
$0.03
BURU
+6.25%
$0.50
PLUG
+13.30%
$3.87
ELBM
+334.95%
$7.17
GWH
+118.14%
$9.07
BITF
+28.33%
$5.39
RGTI
+20.26%
$52.82
NVDA
+2.98%
$188.62
ASST
-35.33%
$1.00
BYND
-48.50%
$1.03
IONZ
-35.04%
$2.21
NVTS
+23.51%
$10.16
JOBY
+2.94%
$16.76
ETHD
+16.10%
$3.82
DNN
+6.94%
$3.07
CAN
+33.93%
$1.45
SNAP
-7.15%
$7.78
QBTS
+23.97%
$40.93
INTC
+2.03%
$37.11
GPUS
-12.50%
$0.41
WULF
-0.58%
$13.51
F
+1.27%
$11.55
AXDX
-61.36%
$0.03
BBD
+1.30%
$3.10
CLF
+4.66%
$13.79
TSLA
+5.01%
$434.23
QS
+16.36%
$17.10
CRML
+56.07%
$23.38
NIO
+6.59%
$7.15
RR
-9.34%
$5.92
TLRY
-1.74%
$1.69
ACHR
+6.09%
$12.70
AMD
+0.40%
$215.76
PWM
+12.50%
$1.17
SOUN
+10.25%
$19.14
RXRX
+4.41%
$5.55
ONDS
+17.24%
$10.81
CIFR
+19.77%
$20.32
MP
+21.94%
$95.52
LAES
+13.49%
$6.14
APLD
+2.14%
$34.71
BTBT
+5.58%
$3.97
VALE
-2.53%
$10.75
SOFI
+4.45%
$27.35
DVLT
-12.36%
$1.66
USAR
+17.01%
$38.15
DFLI
+41.35%
$1.54
PFE
-0.30%
$24.70
WBD
-3.22%
$17.10
QUBT
+12.85%
$21.46
ABAT
+33.25%
$8.99
NAK
+26.47%
$2.56
UAMY
+35.91%
$16.59
RMBL
+60.50%
$3.21
EOSE
+23.62%
$17.08
IREN
+8.04%
$64.58
EPWK
-8.00%
$0.08
ADD
-25.47%
$0.05
ADAP
-0.64%
$0.18
CORZ
+2.66%
$18.52
XCH
+103.41%
$1.68
UUUU
+18.40%
$24.08
AAL
+1.51%
$11.69
RIG
+3.24%
$3.18
MARA
+9.43%
$20.40
TMQ
-9.46%
$5.93
NAKA
-4.05%
$0.83
PLTR
+0.84%
$176.92
SRM
+53.27%
$10.30
NOK
-1.79%
$5.22
IONQ
+18.72%
$83.88
RF
+1.75%
$24.58
BMNR
+7.40%
$56.35
GDXD
-12.99%
$0.74
T
-1.06%
$25.59
QSI
+26.28%
$2.10
BULL
+1.62%
$11.58
NB
+3.81%
$10.78
CLSK
+2.49%
$19.76
BINI
-55.00%
$0.63
MULN
-55.00%
$0.63
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
NEHC
-8.12%
$2.60
WLGS
-5.57%
$0.04
BTG
+3.87%
$5.27
WWR
0.00%
$1.98
KDLY
-7.21%
$0.87
AMC
+0.68%
$2.95
ETWO
0.00%
$3.30
AAPL
+1.24%
$248.32
OKLO
+16.20%
$171.00
HOOD
+1.03%
$140.40
PMAX
+44.78%
$3.75
HPE
+2.76%
$25.07
VHAI
-25.00%
$0.00
YYAI
-12.69%
$0.16
STAI
+39.44%
$0.62
CGBS
-39.47%
$0.03
BURU
+6.25%
$0.50
PLUG
+13.30%
$3.87
ELBM
+334.95%
$7.17
GWH
+118.14%
$9.07
BITF
+28.33%
$5.39
RGTI
+20.26%
$52.82
NVDA
+2.98%
$188.62
ASST
-35.33%
$1.00
BYND
-48.50%
$1.03
IONZ
-35.04%
$2.21
NVTS
+23.51%
$10.16
JOBY
+2.94%
$16.76
ETHD
+16.10%
$3.82
DNN
+6.94%
$3.07
CAN
+33.93%
$1.45
SNAP
-7.15%
$7.78
QBTS
+23.97%
$40.93
INTC
+2.03%
$37.11
GPUS
-12.50%
$0.41
WULF
-0.58%
$13.51
F
+1.27%
$11.55
AXDX
-61.36%
$0.03
BBD
+1.30%
$3.10
CLF
+4.66%
$13.79
TSLA
+5.01%
$434.23
QS
+16.36%
$17.10
CRML
+56.07%
$23.38
NIO
+6.59%
$7.15
RR
-9.34%
$5.92
TLRY
-1.74%
$1.69
ACHR
+6.09%
$12.70
AMD
+0.40%
$215.76
PWM
+12.50%
$1.17
SOUN
+10.25%
$19.14
RXRX
+4.41%
$5.55
ONDS
+17.24%
$10.81
CIFR
+19.77%
$20.32
MP
+21.94%
$95.52
LAES
+13.49%
$6.14
APLD
+2.14%
$34.71
BTBT
+5.58%
$3.97
VALE
-2.53%
$10.75
SOFI
+4.45%
$27.35
DVLT
-12.36%
$1.66
USAR
+17.01%
$38.15
DFLI
+41.35%
$1.54
PFE
-0.30%
$24.70
WBD
-3.22%
$17.10
QUBT
+12.85%
$21.46
ABAT
+33.25%
$8.99
NAK
+26.47%
$2.56
UAMY
+35.91%
$16.59
RMBL
+60.50%
$3.21
EOSE
+23.62%
$17.08
IREN
+8.04%
$64.58
EPWK
-8.00%
$0.08
ADD
-25.47%
$0.05
ADAP
-0.64%
$0.18
CORZ
+2.66%
$18.52
XCH
+103.41%
$1.68
UUUU
+18.40%
$24.08
AAL
+1.51%
$11.69
RIG
+3.24%
$3.18
MARA
+9.43%
$20.40
TMQ
-9.46%
$5.93
NAKA
-4.05%
$0.83
PLTR
+0.84%
$176.92
SRM
+53.27%
$10.30
NOK
-1.79%
$5.22
IONQ
+18.72%
$83.88
RF
+1.75%
$24.58
BMNR
+7.40%
$56.35
GDXD
-12.99%
$0.74
T
-1.06%
$25.59
QSI
+26.28%
$2.10
BULL
+1.62%
$11.58
NB
+3.81%
$10.78
CLSK
+2.49%
$19.76
BINI
-55.00%
$0.63
MULN
-55.00%
$0.63
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
AMZN
+1.81%
$220.30
AVGO
-5.90%
$324.63
NEHC
-8.12%
$2.60
WLGS
-5.57%
$0.04
BTG
+3.87%
$5.27
WWR
0.00%
$1.98
KDLY
-7.21%
$0.87
AMC
+0.68%
$2.95
ETWO
0.00%
$3.30
AAPL
+1.24%
$248.32
OKLO
+16.20%
$171.00
HOOD
+1.03%
$140.40
PMAX
+44.78%
$3.75
HPE
+2.76%
$25.07

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.